The recombinant rat glucagon-like peptide-1 receptor, expressed in an α-cell line, is coupled to adenylyl cyclase activation and intracellular calcium release

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 3, 2005, Pages 182-189

  Dillon, Joseph S ^a,c   Lu, M ^b   Bowen, S ^a   Homan, L L ^a  

^a UNIVERSITY OF IOWA   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF IOWA   (United States)

Author keywords

Alpha cells; GLP 1 receptor; INR1 G9 cells; Intracellular Ca2+ release

Indexed keywords

ADENYLATE CYCLASE; CALCIUM; CYCLIC AMP; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; INOSITOL PHOSPHATE; INSULIN; RECOMBINANT RECEPTOR; VOLTAGE GATED CALCIUM CHANNEL;

ANIMAL CELL; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL ACTIVATION; CONTROLLED STUDY; DEPOLARIZATION; ENZYME ACTIVATION; EXTRACELLULAR CALCIUM; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET ALPHA CELL; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ADENYLATE CYCLASE; ANIMALS; CALCIUM; CELL LINE; CELL MEMBRANE; CYCLIC AMP; ENZYME ACTIVATION; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; INTRACELLULAR MEMBRANES; ISLETS OF LANGERHANS; MEMBRANE POTENTIALS; OSMOLAR CONCENTRATION; PEPTIDE FRAGMENTS; PHOSPHATIDYLINOSITOLS; PROTEIN PRECURSORS; RATS; RECEPTORS, GLUCAGON; RECOMBINANT PROTEINS;

EID: 17144374043     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837526     Document Type: Article

References (56)

1. Abou-Samra A-B, Juppner H, Force T, Freeman M, Kong X, Schipani E, Urena P, Richards J, Bonventre J, Potts J, Kronenberg H, Segre G. Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: A single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. Proc National Acad Sciences USA 1992; 89: 2732-2736
2. Amatruda T, Gerard N, Gerard C, MI S. Specific interactions of chemoattractant factor receptors with G-proteins. J Biol Chem 1993; 14: 10139-10144
3. Berridge M. Inositol trisphosphate and calcium signaling. Nature 1993; 361: 315-325
4. Canonico P, Cronin M, Thorner M, Macleod R. Human pancreatic GRF stimulates phosphatidylinositol-labeling in cultured anterior pituitary cells. Am J Physiol 1983; 245: E587-590
5. Dillon JS, Tanizawa Y, Wheeler MB, Leng XH, Ligon BB, Rabin DU, Yoo-Warren H, Permutt MA, Boyd AE. Cloning and functional expression of the human glucagon-like peptide-1 (GLP-1) receptor. Endocrinology 1993; 133: 1907-1910
6. Ding WG, Renstrom E, Rorsman P, Buschard K, Gromada J. Glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide stimulate calcium-induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism. Diabetes 1997; 46: 792-800
7. Drucker DJ, Philippe J, Mojsov S. Proglucagon gene expression and posttranslational processing in a hamster islet cell line. Endocrinology 1988; 123: 1861-1867
8. Eddlestone G, Oldham S, Lipson L, Premdas F, Biegelman P. Electrical activity, cAMP concentration, and insulin release in mouse pancreatic islets of Langerhans. Am J Physiol 1985; 248: C145-153
9. Exton J. Cell signaling through guanine nucleotide binding regulatory proteins (G proteins) and phospholipases. Eur J Biochem 1997; 243: 10-20
10. Fehmann HC, Habener JF. Homologous desensitization of the insulinotropic glucagon-like peptide-1 (7-37) receptor on insulinoma (H1T-T15) cells. Endocrinology 1991; 128: 2880-2888
11. Coke R, Conlon J. Receptors for glucagon-like peptide-1(7-36) amide on rat insulinoma-derived cells. J Endocrinol 1988; 116: 357-362
12. + channels. J Physiol 2000; 528: 509-520
13. Graber M, Bockenstedt L, Weiss A. Signaling via the inositol phospholipid pathway by T cell antigen receptor is limited by receptor number. Journal of Immunology 1991; 146: 2935-2943
14. Gromada J, Dissing S, Bokvist K, Renstrom E, Frokjaer-Jensen J, Wulff BS, Rorsman P. Glucagon-like peptide 1 increases cytoplasmic calcium in insulin-secreting beta tc3-cells by enhancement of intracellular calcium mobilization. Diabetes 1995; 44: 767-774
15. Gutniak M, Orskov C, Holst JJ, Ahren B, Efendic S. Antidiabetogenic effect of glucagon-like peptide-1(7-36) amide in normal subjects and patients with diabetes mellitus. New Engl J Med 1992; 326: 1316-1322
16. Gutniak MK, Juntti-Berggren L, Hellstrom PM, Guenifi A, Holst JJ, Efendic S. Glucagon-like peptide 1 enhances the insulinotropic effect of glibenclamide in NIDDM patients and in the perfused rat pancreas. Diabetes Care 1996; 19: 857-863
17. Heller RS, Aponte GW. Intra-islet regulation of hormone secretion by glucagon-like peptide-1-(7-36) amide. Am J Physiol 1995; 269: G852-860
18. Heller RS, Kieffer TJ, Habener JF. Insulinotropic glucagon-like peptide 1 receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes 1997; 46: 785-791
19. Henquin J, Meissner H. The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic β-cells: Studies with forskolin. Endocrinology 1984; 115: 1125-1134
20. Holz GG, Leech CA, Heller RS, Castonguay M, Habener JF. cAMP-dependent mobilization of intracellular calcium stores by activation of ryanodine receptors in pancreatic beta-cells. A calcium signaling system stimulated by the insulinotropic hormone glucagon-like peptide-1-(7-37). J Biol Chem 1999; 274: 14147-14156
21. Holz GG, Kuhtreiber WM, Habener JF. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 1993; 361: 362-365
22. Holz GH, Kuhtreiber WM, Habener JF. Induction of glucose competence in pancreatic beta cells by glucagon-like peptide-1(7-37). Transactions of the Association of American Physicians 1992; 105: 260-267
23. Kanse SM, Kreymann B, Ghatei MA, Bloom SR. Identification and characterization of glucagon-like peptide-1 7-36 amide-binding sites in the rat brain and lung. FEBS Letters 1988; 241: 209-212
24. Komatsu R, Matsuyama T, Namba M, Watanabe N, Itoh H, Kono N, Tarui S. Glucagonostatic and insulinotropic action of glucagon like peptide 1-(7-36)-amide. Diabetes 1989; 38: 902-905
25. Ling Z, Wu D, Zambre Y, Flamez D, Drucker DJ, Pipeleers DG, Schuit FC. Glucagon-like peptide 1 receptor signaling influences topography of islet cells in mice. Virchows Archiv 2001; 438: 382-387
26. 2+ mobilization with stimulation of growth hormone release by GH-releasing factor in dispersed normal male pituitary cells. Endocrinology 1986; 118: 239-243
27. Lu M, Soltoff S, Yaney G, Boyd AE. The mechanisms underlying the glucose dependence of arginine vasopressin induced insulin secretion in β cells. Endocrinology 1993 a; 132: 2141-2148
28. Lu M, Wheeler MB, Leng XH, Boyd AE. The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide 1 (7-37). Endocrinology 1993 b; 132: 94-100
29. Marie JC, Rosselin G, Skoglund G. Pancreatic beta-cell receptors and g proteins coupled to adenylyl cyclase. Ann New York Acad Sciences 1996; 805: 122-132
30. Moens K, Heimberg H, Flamez D, Huypens P, Quartier E, Ling Z, Pipeleers D, Gremlich S, Thorens B, Schuit F. Expression and functional activity of glucagon, glucagon-like peptide 1, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells. Diabetes 1996; 45: 257-261
31. Montrose-Rafizadeh C, Avdonin P, Garant MJ, Rodgers BD, Kole S, Yang H, Levine MA, Schwindinger W, Bernier M. Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells. Endocrinology 1999; 140: 1132-1140
32. Munson P, Rodbard D. Ligand: A versatile computerized approach for characterization of ligand binding systems. Analytical Biochemistry 1980; 107: 220-239
33. Nelson T, Gaines K, Rajan A, Berg M, Boyd AE. Increased cytosolic calcium: A signal for sulfonylurea-stimulated insulin release from beta cells. J Biol Chem 1987; 262: 2608-2612
34. Nichols C, Lederer W. The mechanism of kATP channel inhibition by ATP. J General Physiol 1991; 94: 1095-1098
35. αq family members couple parathyroid hormone/PTH related peptide and calcitonin receptors to phospholipase C in COS-7 cells. Mol Endocrinol 1996; 10: 566-574
36. Orskov C, Poulsen SS. Glucagon like peptide-1-(7-36)-amide receptors only in islets of Langerhans. Autoradiographic survey of extra-cerebral tissues in rats. Diabetes 1991; 40: 1292-1296
37. 2+ channels in HIT cells. Diabetes 1989; 38: 874-880
38. Ribalet B, Ciani S, Eddlestone G. ATP mediates both activation and inhibition of kATP channel activity via cAMP dependent protein kinase in insulin secreting cell lines. J General Physiol 1989; 94: 693-796
39. Richter G, Coke R, Coke B, Schmidt H, Arnold R. Characterization of glucagon-like peptide-1(7-36)amide receptors of rat lung membranes by covalent cross-linking. FEBS Letters 1991; 280: 247-250
40. Sato M, Kataoka R, Dingus J, Wilcox M, Hildebrandt J, Lanier S. Factors determining specificity of signal transduction by G-protein coupled receptors. J Biol Chem 1995; 270: 15269-15276
41. Satoh F, Beak SA, Small CJ, Falzon M, Ghatei MA, Bloom SR, Smith DM. Characterization of human and rat glucagon-like peptide-1 receptors in the neurointermediate lobe: Lack of coupling to either stimulation or inhibition of adenylyl cyclase. Endocrinology 2000; 141: 1301-1309
42. Schirra J, Sturm K, Leicht P, Arnold R, Coke B, Katschinski M. Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans. J Clin Invest 1998; 101: 1421-1430
43. 2+ channels due to phosphorylation by cAMP-dependent protein kinase. Nature 1993; 364: 240-243
44. Takaki R, Ono J, Nakamura M, Yokogawa Y, Kumae S, Hiraoka T, Yamaguchi K, Hamaguchi K, Uchida S. Isolation of glucagon-secreting cell lines by cloning insulinoma cells. In Vitro Cellular and Developmental Biology 1986; 22: 120-126
45. Takhar S, Gyomorey S, Su RC, Mathi SK, Li X, Wheeler MB. The third cytoplasmic domain of the GLP-1(7-36 amide) receptor is required for coupling to the adenylyl cyclase system. Endocrinology 1996; 137: 2175-2178
46. Tucker JD, Dhanvantari S, Brubaker PL. Proglucagon processing in islet and intestinal cell lines. Regulatory Peptides 1996; 62: 29-35
47. Uttenthal LO, Blazquez E. Characterization of high-affinity receptors for truncated glucagon-like peptide-1 in rat gastric glands. FEBS Letters 1990; 262: 139-141
48. Wang X, Cahill CM, Pineyro MA, Zhou J, Doyle ME, Egan JM. Glucagon-like peptide-1 regulates the beta cell transcription factor, PDX-1, in insulinoma cells. Endocrinology 1999; 140: 4904-4907
49. Wheeler M, Nishitani J, Buchan A, Kopin A, Chey W, Chang T-M, Leiter A. Identification of a transcriptional enhancer important for enteroendocrine and pancreatic islet cell-specific expression of the secretin gene. Mol Cell Biol 1992; 12: 3531-3539
50. Wheeler MB, Lu M, Dillon JS, Leng XH, Chen C, Boyd AE. Functional expression of the rat glucagon-like peptide-1 receptor, evidence for coupling to both adenylyl cyclase and phospholipase-C. Endocrinology 1993; 133: 57-62
51. Widmann C, Burki E, Dolci W, Thorens B. Signal transduction by the cloned glucagon-like peptide-1 receptor: Comparison with signaling by the endogenous receptors of beta cell lines. Mol Pharmacol 1994; 45: 1029-1035
52. Winicov I, Gershengorn M. Receptor density determines secretory response patterns mediated by inositol lipid derived second messengers. J Biol Chem 1989; 264: 9438-9443
53. Xu G, Stoffers DA, Habener JF, Bonner-Weir S. Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 1999; 48: 2270-2276
54. Yang H, Egan JM, Wang Y, Moyes CD, Roth J, Montrose MH, Montrose-Rafizadeh C. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor. Am J Physiol 1998; 275: C675-683
55. Zar J. Biostatistical Analysis. New Jersey: Prentice-Hall, 1984
56. Zhou J, Wang X, Pineyro MA, Egan JM. Glucagon-like peptide 1 and exendin-4 convert pancreatic AR42J cells into glucagon- and insulin-producing cells. Diabetes 1999; 48: 2358-2366